UNITED STATES ANTIMONY CORP
No SEC Form 4 filings for $UAMY in the last 30 days.
See all $UAMY insider activity →United States Antimony (UAMY) shares fell about 22% week to date after the company reported Q2 results and cut full-year sales guidance. Q2 net income was $0.1M on $7.93M sales, with revenue down nearly 25% YoY and missing analyst expectations. Full-year sales guidance was reduced to $60M-$75M versus prior ~$125M and Street ~$115.3M.
United States Antimony (NYSE:UAMY) shares fell about 25% to $4.92 after the company cut its full-year 2026 revenue guidance to $60 million to $75 million from $125 million, citing lower antimony prices and DLA delivery timing. Q2 2026 revenue was $7.9 million, gross margin 7%, and the stock had gained 31% YTD.
U.S. Antimony (NYSE: UAMY) fell 23.5% by 11:44 a.m. ET after reporting Q2 2026 results. The company posted Q2 2026 revenue of $7.9M, down 24.8% year over year and below analysts’ $21.7M estimate. It cut 2026 revenue guidance to $65M-$75M from $125M and H.C. Wainwright lowered its price target to $9.25 from $11.75.
Over the past 7 days, alphai's AI scored 8 news stories mentioning UAMY (UNITED STATES ANTIMONY CORP). Coverage has skewed bearish: 0 bullish, 1 neutral, and 7 bearish.
Recent UAMY coverage spans earnings, market movers and macro economy.
Guidance reset and Q2 miss are likely to keep downside pressure on UAMY until investors see stabilization in deliveries and contract timing.
The guidance reset tied to lower antimony prices is the dominant near-term driver, likely keeping downside pressure until Q3 DLA execution and price stabilization.
The sell-off is driven by a sharp revenue miss plus a major guidance reset tied to lower antimony spot prices.
The downgrade in revenue outlook is a clear negative catalyst that can pressure the stock into the session.
The earnings miss and guidance reset are driven by a sharp drop in realized antimony prices, compressing margins and raising near-term multiple risk.
alphai scores every news story that mentions UAMY with an AI model for sentiment and relevance, and aggregates insider trades from UNITED STATES ANTIMONY CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
United States Antimony (UAMY) shares fell about 22% week to date after the company reported Q2 results and cut full-year sales guidance. Q2 net income was $0.1M on $7.93M sales, with revenue down nearly 25% YoY and missing analyst expectations. Full-year sales guidance was reduced to $60M-$75M versus prior ~$125M and Street ~$115.3M.
4 min readUnited States Antimony (NYSE:UAMY) shares fell about 25% to $4.92 after the company cut its full-year 2026 revenue guidance to $60 million to $75 million from $125 million, citing lower antimony prices and DLA delivery timing. Q2 2026 revenue was $7.9 million, gross margin 7%, and the stock had gained 31% YTD.
7 min readU.S. Antimony (NYSE: UAMY) fell 23.5% by 11:44 a.m. ET after reporting Q2 2026 results. The company posted Q2 2026 revenue of $7.9M, down 24.8% year over year and below analysts’ $21.7M estimate. It cut 2026 revenue guidance to $65M-$75M from $125M and H.C. Wainwright lowered its price target to $9.25 from $11.75.
3 min readUS stock index futures rose ahead of today’s CPI report, led by tech and semiconductors. S&P futures were up 0.2% and Nasdaq futures up 0.7% at 7:45am ET. CoreWeave shares gained about 18% on stronger-than-expected sales, and Super Micro Computer rose after a revenue forecast beat estimates. CPI consensus: headline +0.1% MoM, core +0.2% MoM.
7 min readUnited States Antimony Corporation (UAMY) shares fell 16.7% pre-open to $5.48 after its Q2 results missed expectations. Revenue dropped 25% year over year to $7.9M versus about $23M consensus. The company cut its 2026 revenue outlook to $60–$75M from $125M, citing a 52% decline in average antimony selling prices and margin compression.
4 min readU.S. stock index futures edged higher ahead of July CPI at 8:30 a.m. ET. Economists expect +0.2% m/m and 3.4% y/y. Nasdaq futures were up 0.4% and S&P 500 up 0.1% by 4:00 a.m. ET. Pre-market movers included CRWV (+15%), NBIS (+8%), SMCI (+9%), and ORCL (+1%).
4 min readUnited States Antimony Corp (UAMY) reported Q2 2026 antimony sales of 428,425 pounds, up 26% YoY, and zeolite revenue up 110% YoY. Revenue fell 25% to $7.9 million as average antimony prices dropped 52%, compressing gross margin to 7%. The company said it has $62.2M cash, total assets of $190.6M, and DLA orders of $57.3M, but lowered full-year revenue guidance to $60-$75M.
7 min readUNITED STATES ANTIMONY CORP (UAMY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622899d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 United States Antimony Corporation Reports Second Quarter and Six Months Ended June 30, 2026 Financial and Operating Results Second Quarter 2026 Revenues of $7.9 Million; Net Income of $0.1 Million Antimony pounds sold up
4 min readU.S. Antimony (UAMY) shares rose about 4.3% after management updated mining operations in Alaska, Montana, and Canada. The company said 2026 would be the first year it uses its own mined antimony ore to meet customer contracts. It also reported progress at Nolan Creek and resumed excavation and trucking to the Radersburg Mill in late July after safety measures requested by Montana regulators.
4 min readUnited States Antimony (NYSE:UAMY) shares fell 11.99% to $5.20, according to Benzinga Pro. The decline was linked to a drop in spot gold of nearly 2% to $3,984.64 per ounce and a 3.6% fall in silver, alongside higher Treasury yields and rising oil prices, Reuters reported, tied to escalating U.S. and Iran tensions.
2 min read
